NIH Challenges’ TRDNT Challenge – Phase II: Stage I supports the development and demonstration of novel RNA-targeting technologies aimed at advancing precision therapeutics for disease.
Alan and Helene Goldberg In Vitro Toxicology Grants support scientists developing toxicology methods to reduce or replace laboratory animals in biomedical research and product safety testing.
This grant supports early-stage projects to develop innovative experimental and computational tools for comprehensive RNA analysis, aiming to overcome current limitations and advance research on RNA’s roles in health and disease.
This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.
NIH Challenges funds digital twin and synthetic data modeling research to advance whole-person health and reduce chronic disease disparities through integrated, AI-ready computational platforms.